Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe W Gray

Showing results (171-180 of 261) with videos related to

Pageof 27
Sort By:
Advanced Materials (Deerfield Beach, Fla.)|June 12, 2021
In Situ Tumor Vaccination with Nanoparticle Co-Delivering CpG and STAT3 siRNA to Effectively Induce Whole-Body Antitumor Immune ResponseWorapol Ngamcherdtrakul, Moataz Reda, Molly A Nelson, et al.
Cancer Discovery|May 26, 2012
A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal adenocarcinomaEric A Collisson, Christy L Trejo, Jillian M Silva, et al.
Cell Systems|July 15, 2019
A Multi-center Study on the Reproducibility of Drug-Response Assays in Mammalian Cell LinesMario Niepel, Marc Hafner, Caitlin E Mills, et al.
Nature Communications|July 23, 2022
Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatmentMoataz Reda, Worapol Ngamcherdtrakul, Molly A Nelson, et al.
Breast Cancer Research : BCR|August 4, 2021
Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CAJoseph P Garay, Rebecca Smith, Kaylyn Devlin, et al.
Breast Cancer Research and Treatment|September 4, 2012
Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumorsLaura A Petrillo, Denise M Wolf, Ann M Kapoun, et al.
Breast Cancer Research : BCR|June 24, 2010
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancerChad J Creighton, Xiaoyong Fu, Bryan T Hennessy, et al.
Cancer Research|August 10, 2011
Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrenceMary Jo Fackler, Christopher B Umbricht, Danielle Williams, et al.
Nature Genetics|August 10, 2004
In situ analyses of genome instability in breast cancerKoei Chin, Carlos Ortiz de Solorzano, David Knowles, et al.
Journal of Clinical Medicine|October 14, 2022
Urinary Comprehensive Genomic Profiling Correlates Urothelial Carcinoma Mutations with Clinical Risk and Efficacy of InterventionVincent T Bicocca, Kevin G Phillips, Daniel S Fischer, et al.
Pageof 27

Showing results (171-180 of 261) with videos related to

Sort By:
Pageof 27
Advanced Materials (Deerfield Beach, Fla.)|June 12, 2021
In Situ Tumor Vaccination with Nanoparticle Co-Delivering CpG and STAT3 siRNA to Effectively Induce Whole-Body Antitumor Immune ResponseWorapol Ngamcherdtrakul, Moataz Reda, Molly A Nelson, et al.
Cancer Discovery|May 26, 2012
A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal adenocarcinomaEric A Collisson, Christy L Trejo, Jillian M Silva, et al.
Cell Systems|July 15, 2019
A Multi-center Study on the Reproducibility of Drug-Response Assays in Mammalian Cell LinesMario Niepel, Marc Hafner, Caitlin E Mills, et al.
Nature Communications|July 23, 2022
Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatmentMoataz Reda, Worapol Ngamcherdtrakul, Molly A Nelson, et al.
Breast Cancer Research : BCR|August 4, 2021
Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CAJoseph P Garay, Rebecca Smith, Kaylyn Devlin, et al.
Breast Cancer Research and Treatment|September 4, 2012
Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumorsLaura A Petrillo, Denise M Wolf, Ann M Kapoun, et al.
Breast Cancer Research : BCR|June 24, 2010
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancerChad J Creighton, Xiaoyong Fu, Bryan T Hennessy, et al.
Cancer Research|August 10, 2011
Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrenceMary Jo Fackler, Christopher B Umbricht, Danielle Williams, et al.
Nature Genetics|August 10, 2004
In situ analyses of genome instability in breast cancerKoei Chin, Carlos Ortiz de Solorzano, David Knowles, et al.
Journal of Clinical Medicine|October 14, 2022
Urinary Comprehensive Genomic Profiling Correlates Urothelial Carcinoma Mutations with Clinical Risk and Efficacy of InterventionVincent T Bicocca, Kevin G Phillips, Daniel S Fischer, et al.
Pageof 27